v3.26.1
BASIS OF PRESENTATION, SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash from the balance sheets to the statements of cash flows (in thousands):
December 31,
20252024
Cash and cash equivalents$53,989 $35,627 
Restricted cash231 232 
Total cash, cash equivalents and restricted cash$54,220 $35,859 
Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share
Potentially dilutive securities not included in the calculation of diluted net loss per share of common stock as of the periods presented, because to do so would be anti-dilutive, were as follows:
December 31,
20252024
Shares issuable upon exercise of stock options12,578,766 10,656,129 
Shares issuable upon conversion election for Term Loan988,142 988,142 
Shares issuable upon exercise of warrant730,769 730,769 
Unvested RSUs1,907,976 1,354,543 
Total16,205,65313,729,583